Navigation Links
Cord Blood America Updates Its Stem Cell Collection Business in China

LAS VEGAS, Oct. 26 /PRNewswire/ -- Cord Blood America, Inc. ( (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced its Chairman, CEO and co-founder, Matthew Schissler, has updated progress on the Company's stem cell collection business in China in an interview with analyst Francis Gaskins.

The entire interview is available at:

In the interview, Mr. Schissler explains some changes to the structure of the transaction since the original announcement on March 31, 2010.  

Several parties, including Cord Blood America, have formed a new company, China Stem Cells, Ltd., to oversee the project.  Mr. Schissler will serve as President of the new company.

Cord Blood America will provide advisory and consulting expertise, proprietary technology and know-how on the processing and storage of stem cells, for which it will receive royalties and an equity stake.  The new company already is completing a laboratory in China for stem cell storage, with storage expected to begin in late 2010 or early 2011.  Plans are moving forward to build a larger laboratory in China within two years.

"This is a more cost effective, smoother process and it gives Cord Blood America a strategic footprint into the Far East," Mr. Schissler said.  He explained that the Chinese are storing stem cells at rates faster than the U.S. and Europe.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at For investor information, visit


Paul Knopick
E & E Communications

SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
2. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
3. Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood
4. Blood Pressure Pills More Effective When Taken at Night
5. First of many Neuro-Biotechs licensed products, "SymPath(R) blood test"
6. Innovations to Omron Healthcare Home Blood Pressure Monitors Provide New Solutions for Consumers
7. Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
8. Effective Self-Management of Blood Glucose Can be Achieved by Using Meters With Advanced Features Paired With Diabetes Education
9. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
10. Adding Lantus® to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients with Type 2 Diabetes
11. China Cord Blood Corporation Announces Mandate for Share Repurchase Program
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):